These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7019873)

  • 1. Immunologic tests of value in diagnosis. 2. Complement.
    Coffey RL; Zile MR; Luskin AT
    Postgrad Med; 1981 Aug; 70(2):183-8. PubMed ID: 7019873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
    Peltier AP; Vial MC; Leroy C; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. I. Variations in the levels of C'1, C'4, C'2 and C'3 and total complement].
    Peltier AP; Vial MC; de Sèze S
    Pathol Biol (Paris); 1970 Nov; 18(21):959-67. PubMed ID: 4921319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Components of the classical complement pathway in systemic lupus erythematosus].
    Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
    Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic assay of the ninth complement complement component: elevation and depletion in rheumatic diseases.
    Ruddy S; Everson LK; Schur PH; Austen KF
    J Exp Med; 1971 Sep; 134(3 Pt 2):259s-275s. PubMed ID: 5570752
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.
    Hedberg H; Lundh B; Laurell AB
    Clin Exp Immunol; 1970 May; 6(5):707-12. PubMed ID: 5477926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of hemolytic complement activity via classical pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():634-6. PubMed ID: 2355588
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A; Whaley K
    J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum complement and synovial complement. Respective variations in rheumatic pathology].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the third component of complement in synovial fluid from arthritic patients.
    Lundh B; Hedberg H; Laurell AB
    Clin Exp Immunol; 1970 Mar; 6(3):407-11. PubMed ID: 5442523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
    Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
    Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The complement system and clinical effects of its disorders].
    Siegert CE; van Es LA; Daha MR
    Ned Tijdschr Geneeskd; 1996 Nov; 140(46):2268-73. PubMed ID: 8984378
    [No Abstract]   [Full Text] [Related]  

  • 14. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of complement proteins in rheumatic disease.
    George D; Glass D
    Clin Rheum Dis; 1983 Apr; 9(1):177-98. PubMed ID: 6603322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on synovial fluid in arthritis. I. The total complement activity. II. The occurrence of mononuclear cells with in vitro cytotoxic effect.
    Hedberg H
    Acta Med Scand Suppl; 1967; 479():1-137. PubMed ID: 4172267
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative studies of complement and its C3 and C4 component levels in patients with rheumatoid arthritis ans systemic lupus erythematosus].
    Brzezińska B; Bragiel I; Skowrońska H
    Pol Arch Med Wewn; 1976 Oct; 56(3):311-21. PubMed ID: 980923
    [No Abstract]   [Full Text] [Related]  

  • 18. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of reduced complement level in the articular fluid. 81 cases].
    Del Pino Montes J; Meyer O; Borda Iriarte O; Belenguer Prieto R; Peltier AP; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):19-21. PubMed ID: 6601817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of complement in serum and synovial fluid in rheumatic diseases].
    Gangl A; Thumb N
    Wien Z Inn Med; 1968; 49(7):251-7. PubMed ID: 5737587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.